Stay updated on Long-Acting HIV Maintenance Clinical Trial
Sign up to get notified when there's something new on the Long-Acting HIV Maintenance Clinical Trial page.

Latest updates to the Long-Acting HIV Maintenance Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to reflect a new version of the study, including the addition of the drug RPV Oral Tablets and the removal of detailed descriptions of the study's methodology and inclusion/exclusion criteria. Collaborators have been confirmed as Janssen Pharmaceuticals and GlaxoSmithKline.SummaryDifference14%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check36 days agoNo Change Detected
- Check72 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.3%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.3%
- Check94 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.0%
Stay in the know with updates to Long-Acting HIV Maintenance Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Acting HIV Maintenance Clinical Trial page.